You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sympt-X G.I.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
Has Results
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)

Terminated
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 26, 2019

Resectable Pancreatic Carcinoma Trial (biological, procedure, other)

Not yet recruiting
  • Resectable Pancreatic Carcinoma
  • Arm I Packed Red Blood Cell Transfusion (Hgb < 7 g/dL)
  • +6 more
  • (no location specified)
Apr 24, 2023

Solid Organ Transplant Trial in Toronto (iParent2Parent Program)

Not yet recruiting
  • Solid Organ Transplant
  • iParent2Parent Program
  • Toronto, Ontario, Canada
    Hospital for Sick Children
Jul 28, 2023

X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Suspended
  • X-linked Severe Combined Immunodeficiency (XSCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)

Recruiting
  • Severe Combined Immunodeficiency, X-Linked
  • Lentiviral vector transduced CD34+ cells
  • London, Greater London, United Kingdom
    Great Ormond Street Hospital for Children NHS Foundation Trust
Mar 15, 2022

Prader-Willi Syndrome Trial in Toronto (Coenzyme Q10, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • Coenzyme Q10
  • Placebo
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Aug 3, 2022

Severe Combined Immunodeficiency, X Linked, Gene Therapy Trial in United Kingdom, United States (autologous CD34+ cell

Recruiting
  • Severe Combined Immunodeficiency, X Linked
  • Gene Therapy
  • autologous CD34+ cell transduced with G2SCID vector
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Hunter Syndrome Trial in Canada, France (Idursulfase-IT, Elaprase)

Not yet recruiting
  • Hunter Syndrome
  • Calgary, Alberta, Canada
  • +3 more
Sep 4, 2023

Hypoxic Ischemic Encephalopathy of Newborn Trial in Toronto (Metformin Hydrochloride)

Not yet recruiting
  • Hypoxic Ischemic Encephalopathy of Newborn
  • Metformin Hydrochloride
  • Toronto, Ontartio, Canada
    The Hospital for Sick Children
Nov 15, 2022

PFS Trial in Qingdao (afatinib)

Recruiting
  • PFS
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

Diabetes, Type 1 Trial in Aurora, London, Toronto (Dapagliflozin 5mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Dapagliflozin 5mg
  • Placebo
  • Aurora, Colorado
  • +2 more
Oct 31, 2022

B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor Trial in Edmonton, Toronto, Montréal (PCLX-001 treated)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • Advanced Solid Tumor
  • PCLX-001 treated
  • Edmonton, Alberta, Canada
  • +2 more
Feb 28, 2022

Long-Term Development of Muscular Dystrophy Outcome Assessments

Not yet recruiting
  • LGMD1A
  • +33 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Aug 3, 2023

    X-Linked Chronic Granulomatous Disease Trial in Paris (X vivo gene therapy)

    Active, not recruiting
    • X-Linked Chronic Granulomatous Disease
    • X vivo gene therapy
    • Paris, France
      Hôpital Necker Enfants Malades
    May 20, 2021

    X-Linked Chronic Granulomatous Disease Trial in London (X vivo gene therapy)

    Active, not recruiting
    • X-Linked Chronic Granulomatous Disease
    • X vivo gene therapy
    • London, United Kingdom
    • +1 more
    May 20, 2021

    Arginase I Deficiency, Hyperargininemia Trial in Worldwide (AEB1102)

    Active, not recruiting
    • Arginase I Deficiency
    • Hyperargininemia
    • Stanford, California
    • +6 more
    Jul 22, 2022

    NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

    Terminated
    • NSCLC
    • +3 more
    • Boston, Massachusetts
    • +17 more
    Dec 20, 2022

    Multiple Sclerosis (MS) Trial in Toronto (Metformin, Placebo)

    Recruiting
    • Multiple Sclerosis (MS)
    • Toronto, Ontario, Canada
    • +1 more
    Mar 15, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • Boston, Massachusetts
    • +5 more
    Jan 7, 2023

    High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

    Recruiting
    • High Grade Serous Carcinoma
    • +2 more
    • Toronto, Ontario, Canada
    • +2 more
    Nov 28, 2022

    NSCLC, EGFR G719X, EGFR L861Q Trial in Chongqing (Furmonertinib 160 mg, Q.D.)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Furmonertinib 160 mg, Q.D.
    • Chongqing, Chongqing, China
    • +2 more
    Sep 16, 2022

    Tumors Trial in Canada, United Kingdom, United States (BI 754091)

    Active, not recruiting
    • Neoplasms
    • BI 754091
    • Sarasota, Florida
    • +12 more
    Jan 9, 2023

    Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

    Completed
    Has Results
    • Neuroblastoma
    • 131I-MIBG
    • +3 more
    • Los Angeles, California
    • +13 more
    May 16, 2022

    Osteogenesis Imperfecta (OI) Trial in Worldwide (Denosumab, No treatment, Alternative osteoporosis medications)

    Terminated
    Has Results
    • Osteogenesis Imperfecta (OI)
    • Los Angeles, California
    • +21 more
    Nov 28, 2022